This study evaluates the cost-effectiveness of laparoscopic assisted supracervical hysterectomy (LASH) compared to the established treatment of Levonorgestrel-releasing intrauterine system (LNG-IUS) for menorrhagia from an NHS perspective.
A cost-utility analysis showed that LNG-IUS resulted in a higher Quality Adjusted Life Year (QALY) gain and was more cost-effective, staying within NHS's £20,000-£30,000/QALY range.
The findings suggest that LASH is not a cost-effective alternative to LNG-IUS for treating menorrhagia, though it could be an option for women who do not wish to have children.